News about 'Announcements'

Notice from the Stop TB Partnership: We are writing to encourage you to sign the Call to Action on Childhood TB. The call was an outcome of an international meeting organized jointly by the European Centre for Disease Prevention and Control (ECDC) and the Stop TB Partnership’s Childhood TB Subgroup...

Dr. Peter Andersen, the Vice President of Vaccine Research and Development at Statens Serum Institut (SSI) and TBVI partner, has been awarded the prestigious Novo Nordisk prize for his work in TB vaccine development. The WGND interviewed Dr. Andersen for our TB R&D Weekly Update on March 8...

The first detailed study of the private tuberculosis (TB) drug market, published on May 4 th , in the PLoS ONE journal, finds that the market is surprisingly large, and has irregular practices that could be driving treatment failures and contributing to the emergence of multidrug-resistant TB (MDR-...

The Stop TB Partnership and the World Health Organization are announcing a call for applications for members to serve on the Global GLC . Deadline for submission of applications is 16 May 2011. A Global GLC Committee (the “gGLC”) is being established that will be 1) a sub-group of the MDR-TB...

Today was the opening of the 2-day Stop TB Partnership’s Coordinating Board (CB) meeting in Washington, D.C. which included welcoming remarks by Dr. Rajiv Shah (Administrator, USAID), Ms. Lois Quam (Executive Director, GHI), and Dr. Howard Koh (Assistant Secretary, U.S. Depart. of HHS). Having the...

The New York Academy of Sciences will be hosting a symposium entitled “New Frontiers in Marine Drug Discovery” on May 20, 2011. This 1-day symposium will overview the current state of the art in Marine Biomedicine and its role in the context of the drug discovery process – from the perspectives of...

Today on World TB Day, the International Scientific Exchange Foundation of China (ISEFC) , announced the signing of a Memorandum of Understanding with the Global Alliance for TB Drug Development (TB Alliance) to establish the Global Health R&D Center of China (GHRC). This innovative center will...

The Médecins Sans Frontières and The Union will release on World TB Day a new report entitled “DR-TB drugs under the microscope” outlining drugs currently available to treat drug-resistant tuberculosis (DR-TB) including product information, sources of the drug, quality status, and price. The...

Photo: David Rochkind On World TB Day March 24, there will be a Congressional Briefing on multi-drug resistant TB (MDR-TB) where David Rochkind, the award winning photographer and Pulitzer Center grantee, will present his reporting and photography on his exploration into the MDR-TB crisis in...

Global Health Primer by Disease This week BIO Ventures for Global Health launched a new online tool called the “Global Health Primer” which aims to be a clearinghouse of information geared to the biotech industry to encourage investments in neglected disease product development. The Primer...

From Guardian (UK) (March 3, 2011) AstraZeneca has joined a consortium to fight tuberculosis around the world with French rival Sanofi-aventis, the University of Cambridge and other research organisations. The More Medicines for Tuberculosis (MM4TB) consortium intends to develop new drugs for...

2010 G-Finder Report The third annual G-Finder report, Neglected Disease Research and Development, was released on February 16, 2011. The report, compiled by the Policy Cures staff using information self-reported by granting and recipient institutions, provides the latest information on the funding...

The Revista Panamericana de Salud Pública / Pan American Journal of Public Health , published by the Pan American Health Organization , announces an open call for original papers, brief communications, and reviews for its next special issue, which will cover topics related to antimicrobial...